genOway S.A.
ALGEN.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €10 | €11 | €11 | €11 |
| % Growth | -15.4% | 6% | -0% | – |
| Cost of Goods Sold | €0 | €6 | €6 | -€8 |
| Gross Profit | €0 | €8 | €7 | €19 |
| % Margin | 0% | 68.9% | 64.5% | 179.2% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €40 | €0 | €5 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €9 | -€34 | €6 | €3 |
| Operating Expenses | €9 | €7 | €6 | €8 |
| Operating Income | €0 | -€1 | -€1 | -€3 |
| % Margin | 1.4% | -10.7% | -11.8% | -23.4% |
| Other Income/Exp. Net | -€0 | €0 | €0 | €1 |
| Pre-Tax Income | €0 | -€1 | -€1 | -€1 |
| Tax Expense | €0 | €2 | -€2 | -€2 |
| Net Income | €0 | €1 | €1 | €1 |
| % Margin | 1.5% | 9.9% | 6.6% | 5.1% |
| EPS | 0.015 | 0.11 | 0.076 | 0.062 |
| % Growth | -86.8% | 44.5% | 22.3% | – |
| EPS Diluted | 0.015 | 0.11 | 0.076 | 0.062 |
| Weighted Avg Shares Out | 10 | 10 | 9 | 9 |
| Weighted Avg Shares Out Dil | 10 | 10 | 9 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €1 | €1 | €3 |
| EBITDA | €0 | €0 | €0 | €6 |
| % Margin | 4% | 3.9% | 3.1% | 53.3% |